Bifunctional antibodies and their use in targeting anti-tumour agents
OwnerPeter Harrisoninventor
Life of this patent
Estimating the term…
Abstract
A bifunctional antibody has affinity for a target site and affinity for an organic molecule covalently linked to a cytotoxic agent or an enzyme capable of converting a prodrug into its cytotoxic form. The antibody may be used in therapy or diagnosis, especially in the treatment of tumours.
Claims21
A bifunctional antibody having affinity for a tumour and for a therapeutic or diagnostic agent, wherein the agent is an organic molecule.
A product comprising a bifunctional antibody having affinity for a tumour and for a therapeutic or diagnostic agent which is an organic molecule covalently bound to a cytotoxic agent or which is a radiolabelled organic molecule.
A method for treatment or diagnosis of a pathological condition wherein said method comprises the administration, to a person or animal in need of said treatment or diagnosis, of an effective amount of radiolabelled 4,4-bis(4-hydroxy-3,5-diiodophenyl)pentanoic acid, radiolabelled N-(4-hydroxy-3,5-diiodobenzoyl)-1,6-hexanediamine.
A pharmaceutical or diagnostic composition comprising a bifunctional antibody having affinity for a tumour and for a therapeutic or diagnostic agent, wherein the agent is an organic molecule.
A method for treating cancer wherein said method comprises administering to a human or animal in need of such treatment an effective amount of a bifunctional antibody having affinity for a tumour and for a therapeutic or diagnostic agent, wherein the agent is an organic molecule.
A diagnostic procedure wherein said procedure utilizes a bifunctional antibody having affinity for a tumour and for a therapeutic or diagnostic agent, wherein the agent is an organic molecule to detect a condition.
Dependencies are inferred from the claim text.